[Retracted] Clinical Study of Heart Failure with Left Ventricular Ejection Fraction Regimen Treated with Entresto

Table 4

Comparison of serum factor levels between the two groups before and after treatment.

Variables	Time	Control	Entresto group
NE (pmol/L)	Pre-treatment	2397.92 ± 370.28	2398.71 ± 369.57
	Posttreatment	1975.84 ± 293.42^#	1702.96 ± 233.68
AngII (ng/L)	Pre-treatment	134.78 ± 19.06	134.25 ± 18.94
	Posttreatment	119.49 ± 16.34^#	108.32 ± 15.18
ALD (pg/ml)	Pre-treatment	349.21 ± 83.52	348.95 ± 83.46
	Posttreatment	319.85 ± 74.61^#	300.26 ± 65.23
MMP-9 (μg/L)	Pre-treatment	171.04 ± 27.13	170.89 ± 26.72
	Posttreatment	161.58 ± 20.37^#	152.43 ± 18.65

Compared with before treatment , compared with the control group, .